The National Comprehensive Cancer Network (NCCN) policy summit, “Primary Care and Oncology Collaboration to Improve Patient ...

A promising target for rare liver cancer, a functional cure for multiple myeloma — and support for people with ovarian cancer.

Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Exicure has concluded subject enrolment in its ongoing randomised Phase II trial on GPC-100 (burixafor) in conjunction with ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

Pieter Sonneveld, MD, PhD, chair of the Erasmus MC Cancer Institute, discussed the findings of a study modeling long-term ...